Menu
Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 2
Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,896 | Dovepress* | 5,896+ | 1,878 | 7,774 | |
| Totals | 5,896 | 1,878 | 7,774 | ||
|
*Since 15 May 2007 +Since July 2016 |
|||||
View citations on Google Scholar